Safety, Tolerability and Immunogenicity of Three Doses of Novartis Meningococcal B Vaccine When Administered to Healthy at-Risk Adults

This study is currently recruiting participants.

Study NCT00560313 Information provided by Novartis

First Received: November 16, 2007 No Changes Posted

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	April 2009
Estimated Primary Completion Date:	No date given